-
Johnson Gets €100m From Europe’s IMI to Accelerate Ebola Vaccine Development
Johnson & Johnson (JNJ) through a consortium, which includes research institutions and non-government organizations, is set to receive around €100m ($115m) from Europe's Innovative Medicines Initiative (IMI) to speed up the development of its Ebola vaccine regimen.
- Categories
- Education, Health Care
- Region
- Europe & Eurasia
- Tags
- impact investing, research, vaccines
-
China Approves New Polio Vaccine, Shows Innovative Muscle
China has approved a new polio vaccine, the first of its kind to be produced in the country, a month after local authorities gave the green light for a home-grown Ebola vaccine amid Beijing's push to become a world leader in producing innovative drugs.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Two Leading Ebola Vaccines Show ‘Acceptable Safety’
The World Health Organization (WHO) announced that two promising Ebola vaccines appear safe and could soon be tested in West Africa, as the agency wrapped up an expert meeting in Geneva earlier today.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Tailor-Made Vaccine Set to Banish Africa’s Meningitis Epidemics
The website of a global partnership formed to wipe out deadly meningitis epidemics in sub-Saharan Africa is closing down with a simple message: "Thank you and goodbye!".
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
J&J and Bavarian Nordic Start Clinical Tests of Ebola Vaccine
Johnson & Johnson has started clinical trials of its experimental Ebola vaccine, which uses a booster from Denmark's Bavarian Nordic, making it the third such shot to enter human testing.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Malaria Vaccine? Genetic Engineering Turns Parasite Into Vaccine Candidate
Malaria is one of the Great Diseases. This mosquito-borne illness killed some 627,000 people in 2012, most of them children in sub-Saharan Africa. Efforts in the last decade have cut mortality rates for the disease by an impressive 45 percent, but malaria continues to be a massive public health burden wherever it persists.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Ebola Vaccine Trial in Africa May Support More Potent Version
An experimental Ebola vaccine showed it was safe and generated an immune response in healthy Ugandan adults in a clinical trial that bodes well for a more potent version undergoing testing.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
The Limits of Tiered Pricing (Part 2): Harvard’s Suerie Moon says policy tweaks could help ensure access to medicine
In Part 2 of a two-part post, Harvard’s Suerie Moon suggests four ways tiered-pricing policies for pharmaceuticals might be improved in the short-to-medium term, and also highlights some alternatives – including rewarding innovation.
- Categories
- Health Care
- Tags
- vaccines
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.